Operating Cash Flow (Statement)

-$39.50M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$39.50Mperiod endingJun 30, 2026

NVAX Cash from Operations (-$3.30M → -$39.50M)

Annual operating cash flow (statement)

High-resolution chart · PNG

NVAX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	-244,635,000
Dec 31, 2024	-87,263,000
Dec 31, 2023	-713,967,000
Dec 31, 2022	-415,937,000
Dec 31, 2021	322,946,000
Dec 31, 2020	-42,541,000
Dec 31, 2019	-136,623,000
Dec 31, 2018	-184,825,000
Dec 31, 2017	-138,696,000
Dec 31, 2016	-255,467,000
Dec 31, 2015	-126,090,000
Dec 31, 2014	-67,014,000
Dec 31, 2013	-45,359,000
Dec 31, 2012	-18,229,000
Dec 31, 2011	-23,629,000
Dec 31, 2010	-32,852,000
Dec 31, 2009	-32,830,000
Dec 31, 2008	-24,310,000
Dec 31, 2007	-26,742,000
Dec 31, 2006	-14,810,000
Dec 31, 2005	-5,809,000
Dec 31, 2004	-30,099,000
Dec 31, 2003	-17,547,000
Dec 31, 2002	-21,066,000
Dec 31, 2001	-4,566,000
Dec 31, 2000	-10,044,000
Dec 31, 1999	-3,700,000
Dec 31, 1998	-3,600,000
Dec 31, 1997	-4,200,000
Dec 31, 1996	-3,300,000